1.Therapeutic options and prognosis of synchronous multiple primary colorectal carcinomas.
Li-bin XU ; Yong-fu SHAO ; Dong-bing ZHAO ; Tie-cheng WU ; Hai-peng WANG ; Ping ZHAO
Chinese Journal of Oncology 2005;27(7):435-437
OBJECTIVETo investigate the therapeutic principles and prognosis of synchronous primary colorectal carcinomas (SCC).
METHODSThe data of 66 SCC patients surgically treated from 1984 to 2003 were retrospectively reviewed.
RESULTSThe synchronous primary colorectal carcinomas were diagnosed and resected simultaneously in 65 patients except one that was misdiagnosed. Thirty patients underwent combined resection, 35 patients segmental resection. Sixty-two patients received radical resection, while three patients had palliative resection due to hepatic metastasis. The overall postoperative 3-, 5-, 10-year survival rates were 70.3%, 60.0%, 40.6%, respectively. In the patients who had simultaneous radical resection, the 3-, 5-, 10-year survival rates were 76.0%, 65.9%, 46.4% respectively.
CONCLUSIONThe extent of resection should be individually determined by the lesion location, extent and distance between the lesions, as well as the patient's general condition. More extensive bowel resection, such as total or subtotal colectomy are suggested for those patients with hereditary nonpolyposis colorectal carcinoma syndrome in order to reduce or avoid the risk of metachronous colorectal carcinoma. The postoperative survival in patients with synchronous primary colorectal carcinoma is similar to those with solitary lesion.
Adult ; Aged ; Colorectal Neoplasms ; mortality ; pathology ; surgery ; Colorectal Neoplasms, Hereditary Nonpolyposis ; genetics ; surgery ; Female ; Humans ; Male ; Middle Aged ; Neoplasms, Multiple Primary ; genetics ; surgery ; Ovarian Neoplasms ; surgery ; Prognosis ; Stomach Neoplasms ; surgery ; Survival Rate
2.Clinicopathological characteristics of colorectal carcinoma in the elderly.
Kaixiong TAO ; Jinbo GAO ; Guobin WANG
Chinese Journal of Gastrointestinal Surgery 2016;19(5):495-498
Elderly patients with colorectal cancer have different clincopathological characteristics from younger patients. Colorectal cancers tend to localize in the proximal colon, from cecum to the splenic flexure in the elderly patients. Changes in the stools, rectal bleeding or black stool, abdominal pain, fatigue, weight loss and anemia are the common symptoms. Analysis showed that age is one of independent risk factors for lower completion rates of colonoscopy. Therefore, the choice of diagnosis methods in elderly patients should be careful. Achieving a clear diagnosis and avoiding complications should be considered at the same time. Most colorectal cancers in elderly are highly and moderately differentiated adenocarcinomas and locally advanced, and have less lymphatic and blood metastasis. The proportion of poorly differentiated adenocarcinoma increases with the increase of age, which should be concerned. Multiple colorectal cancers and colorectal cancer with extra-colorectal malignancy are not rare in the elderly patients. The common extra-colorectal tumors consist of gastric cancer, lung cancer, biliary carcinoma, pancreas cancer and malignancy from blood system. Molecular events, such as mutations of KARS, BRAF, TP53 and deficiency of DNA mismatch repair, are more frequent in elderly colorectal cancer patients. Many factors have impact on treatment decision in elderly patients with colorectal cancer, including age, comorbidities, physiological functions of organs and willingness of patients and their relatives. Although surgery is still the main treatment, the proportion of radical surgery is lower and emergency surgery is higher as compared to younger patients. With the development of minimally invasive surgical techniques and advances in anesthesia and perioperative management, laparoscopic surgery has become widespread in elderly patients with colorectal cancer. In addition, more attention should be paid to adjuvant therapy. Comprehensive individualized treatment plan should be taken to improve outcomes.
Adenocarcinoma
;
pathology
;
Aged
;
Colonoscopy
;
Colorectal Neoplasms
;
diagnosis
;
genetics
;
pathology
;
surgery
;
Humans
;
Laparoscopy
;
Mutation
;
Risk Factors
3.Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms.
Young Beak KIM ; Sun Young LEE ; Jeong Hwan KIM ; In Kyung SUNG ; Hyung Seok PARK ; Chan Sup SHIM ; Hye Seung HAN
Gut and Liver 2016;10(2):220-227
BACKGROUND/AIMS: Microsatellite instability (MSI) plays a crucial role in gastrointestinal carcinogenesis. The aim of this study was to clarify whether MSI is a useful marker for predicting synchronous gastric and colorectal neoplasms. METHODS: Consecutive patients who underwent both esophagogastroduodenoscopy and colonoscopy before the resection of gastric or colorectal cancers were included. MSI was analyzed using two mononucleotide and three dinucleotide markers. RESULTS: In total, 434 gastric cancers (372 microsatellite stability [MSS], 21 low incidence of MSI [MSI-L], and 41 high incidence of MSI [MSI-H]) and 162 colorectal cancers (138 MSS, 9 MSI-L, and 15 MSI-H) were included. Patients with MSI gastric cancer had a higher prevalence of synchronous colorectal cancer, colorectal adenoma, and gastric adenoma than those with MSS gastric cancers (4.8% vs 0.5%, p=0.023; 11.3% vs 3.2%, p=0.011; 3.2% vs 1.2%, p=0.00, respectively). The prevalence of synchronous colorectal adenomas was highest in MSI-L gastric cancers (19.0%), compared with MSI-H (7.3%) or MSS (3.2%) gastric cancers (p=0.002). In addition, there were no significant differences in the prevalence rates of synchronous colorectal adenoma among the MSI-H (13.3%), MSI-L (11.1%), and MSS (12.3%) colorectal cancers (p=0.987). CONCLUSIONS: The presence of MSI in gastric cancer may be a predictor of synchronous gastric and colorectal neoplasms, whereas MSI in colorectal cancer is not a predictor of synchronous colorectal adenoma.
Adenoma/*genetics/surgery
;
Aged
;
Colonoscopy
;
Colorectal Neoplasms/*genetics/surgery
;
Endoscopy, Digestive System
;
Female
;
Humans
;
Male
;
*Microsatellite Instability
;
Middle Aged
;
Neoplasms, Multiple Primary/*genetics/surgery
;
Predictive Value of Tests
;
Stomach Neoplasms/*genetics/surgery
4.Expression of Cyclooxygenase-2 and its Relationship to p53 Accumulation in Colorectal Cancers.
Sung Chul LIM ; Tae Bum LEE ; Cheol Hee CHOI ; So Yeon RYU ; Kyung Jong KIM ; Young Don MIN
Yonsei Medical Journal 2007;48(3):495-501
PURPOSE: Cyclooxygenase (COX)-2 is an inducible isoform responsive to cytokines, mitogens, and growth factors, and is believed to be an important enzyme related to colorectal cancer (CRC). Existing evidence suggests that COX-2 expression is normally suppressed by wild-type p53 but not mutant p53, suggesting that loss of p53 function may result in the induction of COX-2 expression. The aim of this study was to determine the relationship between COX-2 expression and p53 levels in CRC. MATERIALS AND METHODS: Patients with sporadic colorectal adenocarcinoma (n=161) who underwent curative surgery in Chosun University Hospital were enrolled in this study. Expression of COX-2 and p53 proteins was examined by immunohistochemistry in paraffin-embedded cancer tissue blocks, and the relationship between COX-2 and/or p53 expression with clinicopathologic parameters was analyzed. RESUTLS: Expression of COX- 2 was positive in 47.8% of colorectal cancers, and significantly associated with the depth of tumor invasion (p= 0.042). In contrast, p53 was positive in 50.3% of the cases, and was associated with both age (p=0.025) and the depth of tumor invasion (p=0.014). There was no correlation between COX-2 expression and p53 expression (p=0.118). CONCLUSION: These results suggest that COX-2 expression might play an important role in the progression of colorectal cancer. However, COX-2 expression was not associated with mutational p53. Further studies are needed to clarify the regulatory mechanisms governing COX-2 overexpression in colorectal cancers.
Adenocarcinoma/*metabolism/pathology/surgery
;
Aged
;
Colorectal Neoplasms/*metabolism/pathology/surgery
;
Cyclooxygenase 2/*metabolism
;
Female
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
;
Mutation
;
Tumor Suppressor Protein p53/genetics/*metabolism
5.Progress in the gene diagnosis and treatment of hereditary colorectal cancer.
Tao PAN ; Yue HU ; Yin YUAN ; Su-zhan ZHANG
Chinese Journal of Oncology 2013;35(10):721-725
Adenomatous Polyposis Coli
;
diagnosis
;
drug therapy
;
genetics
;
surgery
;
Antineoplastic Agents
;
therapeutic use
;
Colectomy
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
diagnosis
;
drug therapy
;
genetics
;
surgery
;
DNA Mismatch Repair
;
Humans
;
Ileostomy
;
Peutz-Jeghers Syndrome
;
diagnosis
;
drug therapy
;
genetics
;
surgery
6.Pathogenesis and Management of Serrated Polyps: Current Status and Future Directions.
Gut and Liver 2014;8(6):582-589
Hyperplastic or serrated polyps were once believed to have little to no clinical significance. A subset of these polyps are now considered to be precursors to colorectal cancers (CRC) in the serrated pathway that may account for at least 15% of all tumors. The serrated pathway is distinct from the two other CRC pathways and involves an epigenetic hypermethylation mechanism of CpG islands within promoter regions of tumor suppressor genes. This process results in the formation of CpG island methylator phenotype tumors. Serrated polyps are divided into hyperplastic polyps, sessile serrated adenomas/polyps (SSA/Ps), and traditional serrated adenomas (TSAs). The SSA/P and the TSA have the potential for dysplasia and subsequent malignant transformation. The SSA/Ps are more common and are more likely to be flat than TSAs. Their flat morphology may make them difficult to detect and thus explain the variation in detection rates among endoscopists. Challenges for endoscopists also include the difficulty in pathological interpretation as well surveillance of these lesions. Furthermore, serrated polyps may be inadequately resected by endoscopists. Thus, it is not surprising that the serrated pathway has been linked with interval cancers. This review will provide the physician or clinician with the knowledge to manage patients with serrated polyps.
Adaptor Proteins, Signal Transducing/genetics/metabolism
;
Adenomatous Polyps/genetics/metabolism/*surgery
;
Colonoscopy
;
Colorectal Neoplasms/genetics/metabolism/*surgery
;
DNA Methylation
;
Humans
;
Intestinal Polyposis/genetics/metabolism/*surgery
;
Intestinal Polyps/genetics/metabolism/*surgery
;
Nuclear Proteins/genetics/metabolism
;
Proto-Oncogene Proteins/genetics/metabolism
;
Proto-Oncogene Proteins B-raf/genetics/metabolism
;
ras Proteins/genetics/metabolism
7.Clinicopathologic Impacts of Poorly Differentiated Cluster-Based Grading System in Colorectal Carcinoma.
Jeong Won KIM ; Mi Kyung SHIN ; Byung Chun KIM
Journal of Korean Medical Science 2015;30(1):16-23
Differentiation-based histologic grading of colorectal carcinoma (CRC) is widely used, but its clinical impact is limited by insufficient prognostic value, interobserver disagreement, and the difficulty of its application to CRC with specific histologic types such as mucinous and medullary carcinoma. A recently proposed novel grading system based on quantifying poorly differentiated clusters (PDCs) claims to have the advantages of reproducibility and improved prognostic value, and might apply to heterogeneous CRC. We aimed to validate the clinicopathologic significance of the PDCs-based grading system and to determine the relationship between this grading system and microsatellite instability (MSI). Two hundred and one patients who had undergone radical surgery were reviewed. Based on the number of PDCs, 85, 58, and 58 tumors were classified as grade (G) 1 (42.3%), G2 (28.9%), and G3 (28.9%), respectively. PDCs-based grade was significantly associated with T, N, and M stages; lymphovascular invasion; conventional histologic grade; and frequent tumor budding (all P <0.001). In multivariate analysis, PDCs-based grade was found to be an independent prognostic factor for disease-free survival (P = 0.022; hazard ratio, 3.709 [G2], 7.461 [G3]). G3 CRC significantly correlated with high MSI (MSI-H) compared to G1 and G2 (P = 0.002; odds ratio, 5.750). In conclusion, this novel grading would provide valuable prognostic information to a greater number of patients and would require continued verification. PDCs-based grading is feasible for CRCs with heterogeneous morphology, and we propose that the association between G3 and MSI-H be further evaluated in different histological subtypes of CRC.
Colorectal Neoplasms/*genetics/*pathology/surgery
;
Disease-Free Survival
;
Female
;
Humans
;
Lymphatic Metastasis/pathology
;
Male
;
*Microsatellite Instability
;
Middle Aged
;
Neoplasm Grading/*methods
;
Tumor Burden/*physiology
8.Lynch syndrome-related endometrial carcinoma.
Chinese Journal of Pathology 2012;41(7):494-497
Adaptor Proteins, Signal Transducing
;
metabolism
;
Adenocarcinoma, Clear Cell
;
genetics
;
metabolism
;
pathology
;
surgery
;
Adenosine Triphosphatases
;
metabolism
;
Age Factors
;
Carcinoma, Endometrioid
;
genetics
;
metabolism
;
pathology
;
surgery
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
genetics
;
metabolism
;
pathology
;
surgery
;
Cystadenocarcinoma, Serous
;
genetics
;
metabolism
;
pathology
;
surgery
;
DNA Mismatch Repair
;
DNA Repair Enzymes
;
metabolism
;
DNA-Binding Proteins
;
metabolism
;
Endometrial Neoplasms
;
genetics
;
metabolism
;
pathology
;
surgery
;
Female
;
Humans
;
Mismatch Repair Endonuclease PMS2
;
MutL Protein Homolog 1
;
MutS Homolog 2 Protein
;
metabolism
;
Neoplasms, Multiple Primary
;
genetics
;
metabolism
;
pathology
;
surgery
;
Nuclear Proteins
;
metabolism
9.Clinicopathologic characteristics, diagnosis, and treatment of 30 patients with hereditary nonpolyposis colorectal cancer.
Heli LIU ; Zhongshu YAN ; Guoqing LIAO ; Hongling YIN ; Xiaoyong XIE
Journal of Central South University(Medical Sciences) 2009;34(8):757-761
OBJECTIVE:
To explore the clinicopathologic and molecular characteristics of hereditary nonpolyposis colorectal cancer (HNPCC), and to improve the level of diagnosis and treatments of HNPCC.
METHODS:
Thirty HNPCC patients (HNPCC group) who were treated in Xiangya Hospital were retrospectively analyzed, and 25 patients with sporadic colorectal cancer in the same duration were randomly chosen as a control group. The onset of age, location of tumor, pathological type, treatment method, and prognosis were compared in the 2 groups. The expression loss rate of mismatch repair gene (MMR) MLH1 and MSH2 in the 2 groups was detected by immunohistochemistry.
RESULTS:
The onset age in the HNPCC group was earlier than that in the control group (P<0.05). The rate of proximal colonic tumor the occurrence of multiple tumors, and the proportion of well differentiated adenocarcinoma in the HNPCC group were all higher than those in the control group (P<0.05). The expression loss rate of MLH1 and MSH2 in the HNPCC group was higher than that in the control group (P<0.05). One third in the HNPCC group received subtotal proctocolectomy. The prognosis of HNPCC patients was comparable with that of patients with sporadic colorectal cancer (P>0.05).
CONCLUSION
HNPCC patients are characterized with early onset associating with multiple tumors. The accuracy of diagnosis can be improved by combining the detection of MMR gene. Optimal surgical treatment and close follow-up may bring good result to HNPCC patients.
Adaptor Proteins, Signal Transducing
;
genetics
;
metabolism
;
Adenocarcinoma
;
diagnosis
;
genetics
;
pathology
;
surgery
;
Aged
;
Case-Control Studies
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
diagnosis
;
genetics
;
pathology
;
surgery
;
Endometrial Neoplasms
;
pathology
;
Female
;
Humans
;
Male
;
Middle Aged
;
MutL Protein Homolog 1
;
MutS Homolog 2 Protein
;
genetics
;
metabolism
;
Mutation
;
Neoplasms, Second Primary
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
Retrospective Studies
10.Study on the prognostic factors of colorectal cancer after radical resection and on suggested model for prediction.
Yan-fang YANG ; Pei-zhen LI ; Xiao-bo LIANG ; Xiao-li HAN ; Yao-ping LI ; Juan CONG
Chinese Journal of Epidemiology 2005;26(3):214-217
OBJECTIVETo study the factors of colorectal cancer (CRC) after radical resection to provide data predicting the prognosis of the patients.
METHODS120 cases of CRC were collected in this study. Medical clinical records and 5-year follow-up data were reviewed. Streptavidin-peroxidase immunohistochemical technique was used to detect the expression of p53, C-erbB-2, nm23-H(1) and Ras on formalin-fixed, paraffin embedded sections of CRC from the 120 patients.
RESULTSResults showed that the rates of positive expression of p53, C-erbB-2, Ras and nm23-H(1) were 62.5% (75/120), 25.8% (31/120), 80.0% (96/120) and 60.8% (73/120) respectively in the CRC tissue. All pathological variables and biological markers were analyzed with Cox regression model (alpha = 0.05). Eight distinguished prognostic factors were identified in the univariate analysis as: macroscopic configuration, histology grade, depth of invasion of intestinal, lymph nodes metastasis, Dukes' classification, p53, Ras and nm23-H(1). The results of multivariate analysis (alpha = 0.05) indicated that the independent prognostic factors were Dukes' classification, p53 and nm23-H(1) (P = 0.000), with relative risk of 3.06, 6.02 and 0.40, respectively. A prognostic model: h(t, x) = h(0)(t)exp (-0.9269X(14) + 1.1197X(10) + 1.7948X(11)) was established. Sensitivity, specificity agreement and reliability of the model and Kappa were 79.1%, 83.0%, 80.8% and 0.62, respectively.
CONCLUSIONDukes' classification, p53 and nm23-H(1)seemed to be independent and important prognostic factors. This prognostic model could be used to evaluate the prognosis of patients with CRC by clinicians.
Adult ; Aged ; Colorectal Neoplasms ; diagnosis ; surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Receptor, ErbB-2 ; biosynthesis ; genetics ; Survival Analysis ; Tumor Suppressor Protein p53 ; biosynthesis ; genetics